Even if the antiproliferative effect of SCD1 inhibition is common to many neoplastic cell types including melanoma and lung, bladder, and breast cancer [112,113,114,115], the role of SCD1 in tumorigenesis cannot be generalized. Here, SCD is linked to breast cancer.